Draeger Receives FDA Clearance for Evita V800 Software Update with New Ventilation Features

Draeger has received FDA 510(k) clearance to market the latest software update for its Evita V800 ventilator. The version 3.10 software release introduces additional features designed to enhance mechanical ventilation for patients with pulmonary conditions, including acute respiratory distress syndrome (ARDS).

The software update includes several new capabilities. A decelerating flow feature during volume control ventilation provides clinician-controlled flow intended to match patient demand while incorporating recommended ARDSnet safeguards. The system also adds guidance maps for low and high PEEP-FiO2 tables to facilitate clinical decision-making in determining optimal PEEP and FiO2 settings. Additionally, the update enables calculation of driving pressure and semi-automated static compliance measurements, which can assist clinicians in managing inspiratory settings and potentially reduce the risk of ventilator-induced lung injury (VILI).

Lothar Thielen, President and CEO of Draeger, stated that the company continues to be at the forefront of technology, and the addition of these new features for the Evita V800 represents another example of Draeger’s commitment to research and development for respiratory care.